Devadas B, Lu T, Katoh A, Kishore N S, Wade A C, Mehta P P, Rudnick D A, Bryant M L, Adams S P, Li Q
Monsanto Company, St. Louis, Missouri 63198.
J Biol Chem. 1992 Apr 15;267(11):7224-39.
Covalent attachment of myristic acid (C14:0) to the amino-terminal glycine residue of a variety of eukaryotic cellular and viral proteins can have a profound influence on their biological properties. The enzyme that catalyzes this modification, myristoyl-CoA-protein N-myristoyltransferase (NMT), has been identified as a potential target for antiviral and antifungal therapy. Its reaction mechanism is ordered Bi Bi with myristoyl-CoA binding occurring before binding of peptide and CoA release preceding release of myristoylpeptide. Perturbations in the binding of its acyl-CoA substrate would therefore be expected to have an important influence on catalysis. We have synthesized 56 analogs of myristic acid (C14:0) to further characterize the acyl-CoA binding site of Saccharomyces cerevisiae NMT. The activity of fatty acid analogs was assessed using a coupled in vitro assay system that employed the reportedly nonspecific Pseudomonas acyl-CoA synthetase, purified S. cerevisiae NMT, and octapeptide substrates derived from residues 2-9 of the catalytic subunit of cyclic AMP-dependent protein kinase and the Pr55gag polyprotein precursor of human immunodeficiency virus I (HIV-I). Analysis of ketocarbonyl-, ester-, and amide-containing myristic acid analogs (the latter in two isomeric arrangements, the acylamino acid (-CO-NH-) and the amide (-NH-CO)) indicated that the enzyme's binding site is able to accommodate a dipolar protrusion from C4 through C13. This includes the region of the acyl chain occurring near C5-C6 (numbered from carboxyl) that appears to be bound in a bent conformation of 140-150 degrees. The activities of NMT's acyl-CoA substrates decrease with increasing polarity. This relationship was particularly apparent from an analysis of a series of analogs in which the hydrocarbon chain was terminated by (i) an azido group or (ii) one of three nitrogen heterocycles (imidazole, triazole, and tetrazole) alkylated at either nitrogen or carbon. This inverse relationship between polarity and activity was confirmed after comparison of the activities of the closely related ester- or amide-containing tetradecanoyl-CoA derivatives. Members from all of the analog series were surveyed to determine whether they could inhibit replication of human immunodeficiency virus I (HIV-I), a retrovirus that depends upon N-myristoylation of its Pr55gag for propagation. 12-Azidododecanoic acid was the most active analog tested, producing a 60-90% inhibition of viral production in both acutely and chronically infected T-lymphocyte cell lines at a concentration of 10-50 microM without associated cellular toxicity.
肉豆蔻酸(C14:0)与多种真核细胞和病毒蛋白的氨基末端甘氨酸残基共价连接,可对其生物学特性产生深远影响。催化这种修饰的酶,肉豆蔻酰辅酶A - 蛋白N - 肉豆蔻酰基转移酶(NMT),已被确定为抗病毒和抗真菌治疗的潜在靶点。其反应机制为有序的双底物双产物机制,肉豆蔻酰辅酶A先结合,然后是肽结合,辅酶A释放先于肉豆蔻酰肽释放。因此,预计其酰基辅酶A底物结合的扰动会对催化作用产生重要影响。我们合成了56种肉豆蔻酸(C14:0)类似物,以进一步表征酿酒酵母NMT的酰基辅酶A结合位点。使用一种偶联的体外测定系统评估脂肪酸类似物的活性,该系统采用据报道非特异性的铜绿假单胞菌酰基辅酶A合成酶、纯化的酿酒酵母NMT以及源自环磷酸腺苷依赖性蛋白激酶催化亚基2 - 9位残基和人类免疫缺陷病毒I(HIV - I)的Pr55gag多蛋白前体的八肽底物。对含酮羰基、酯和酰胺的肉豆蔻酸类似物(后者有两种异构体排列,酰基氨基酸(-CO - NH -)和酰胺(-NH - CO))的分析表明,该酶的结合位点能够容纳从C4到C13的偶极突出部分。这包括酰基链在C5 - C6附近(从羧基开始编号)的区域,该区域似乎以140 - 150度的弯曲构象结合。NMT的酰基辅酶A底物的活性随着极性增加而降低。从对一系列类似物的分析中这种关系尤为明显,其中烃链由(i)叠氮基或(ii)在氮或碳上烷基化的三种氮杂环(咪唑、三唑和四氮唑)之一终止。在比较密切相关的含酯或酰胺的十四烷酰辅酶A衍生物的活性后,证实了极性与活性之间的这种反比关系。对所有类似物系列的成员进行了调查,以确定它们是否能抑制人类免疫缺陷病毒I(HIV - I)的复制,HIV - I是一种逆转录病毒,其传播依赖于Pr55gag的N - 肉豆蔻酰化。12 - 叠氮十二烷酸是测试的最具活性的类似物,在浓度为10 - 50 microM时,对急性和慢性感染的T淋巴细胞细胞系中的病毒产生有60 - 90%的抑制作用,且无相关细胞毒性。